Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 12:42PM ET
73.89
Dollar change
-0.49
Percentage change
-0.65
%
IndexS&P 500 P/E11.43 EPS (ttm)6.47 Insider Own0.18% Shs Outstand1.29B Perf Week-4.29%
Market Cap92.98B Forward P/E8.00 EPS next Y9.23 Insider Trans-1.20% Shs Float1.26B Perf Month-0.65%
Income8.34B PEG3.09 EPS next Q1.74 Inst Own82.44% Short Float2.45% Perf Quarter10.44%
Sales358.27B P/S0.26 EPS this Y-4.85% Inst Trans0.60% Short Ratio2.73 Perf Half Y10.56%
Book/sh59.36 P/B1.24 EPS next Y11.03% ROA3.38% Short Interest30.76M Perf Year-10.41%
Cash/sh9.17 P/C8.05 EPS next 5Y3.69% ROE11.32% 52W Range64.41 - 83.26 Perf YTD-6.43%
Dividend Est.2.48 (3.35%) P/FCF8.94 EPS past 5Y- ROI5.52% 52W High-11.26% Beta0.50
Dividend TTM2.48 (3.36%) Quick Ratio0.63 Sales past 5Y13.36% Gross Margin15.33% 52W Low14.71% ATR (14)1.59
Dividend Ex-DateJan 19, 2024 Current Ratio0.86 EPS Y/Y TTM104.83% Oper. Margin4.35% RSI (14)40.36 Volatility1.97% 2.02%
Employees300000 Debt/Eq1.04 Sales Y/Y TTM11.05% Profit Margin2.33% Recom1.67 Target Price89.25
Option/ShortYes / Yes LT Debt/Eq0.98 EPS Q/Q-9.33% Payout38.34% Rel Volume0.73 Prev Close74.37
Sales Surprise3.59% EPS Surprise6.50% Sales Q/Q12.02% EarningsFeb 07 BMO Avg Volume11.26M Price73.89
SMA20-2.44% SMA50-3.47% SMA2002.91% Trades Volume4,239,654 Change-0.65%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Outperform $88
Dec-22-23Initiated HSBC Securities Buy $94
Sep-19-23Upgrade Evercore ISI In-line → Outperform $81 → $83
Sep-12-23Upgrade Wolfe Research Peer Perform → Outperform $80
Aug-18-23Downgrade Edward Jones Buy → Hold
May-26-23Initiated Piper Sandler Overweight $85
Apr-21-23Initiated Cantor Fitzgerald Overweight $87
Jan-03-23Downgrade Evercore ISI Outperform → In-line $120 → $100
Nov-23-22Resumed Morgan Stanley Overweight $124 → $119
Jun-17-22Initiated Loop Capital Buy $120
Today 11:40AM
03:40AM
Feb-29-24 09:10PM
09:33AM
09:19AM
03:17AM Loading…
03:17AM
Feb-28-24 08:39PM
05:34PM
04:00PM
Feb-26-24 02:18PM
09:00AM
Feb-22-24 05:54PM
Feb-21-24 08:45PM
09:00AM
Feb-18-24 03:20PM
12:09AM Loading…
Feb-17-24 12:09AM
Feb-14-24 01:42PM
10:05AM
07:47AM
Feb-13-24 09:00AM
Feb-12-24 08:25AM
Feb-11-24 08:00AM
Feb-10-24 11:40AM
08:30AM
Feb-09-24 07:44AM
12:30AM
12:30AM
12:30AM
Feb-08-24 06:09PM
11:50AM
10:00AM Loading…
10:00AM
12:10AM
Feb-07-24 07:35PM
02:00PM
01:54PM
01:00PM
11:58AM
11:22AM
10:36AM
09:53AM
09:49AM
09:30AM
07:23AM
07:23AM
07:23AM
07:10AM
07:08AM
06:55AM
06:52AM
06:44AM
06:40AM
06:35AM
06:30AM
03:37AM
Feb-06-24 05:30PM
03:17AM
Feb-05-24 04:13PM
03:26PM
03:02AM
Feb-02-24 09:15AM
Feb-01-24 05:45PM
Jan-31-24 09:03PM
04:15PM
03:16PM
10:00AM
Jan-30-24 09:00AM
Jan-28-24 09:10AM
Jan-26-24 05:45PM
04:00PM
02:00PM
Jan-25-24 08:09PM
10:06AM
08:00AM
Jan-24-24 11:43AM
09:54AM
09:32AM
Jan-23-24 10:00PM
04:16AM
Jan-22-24 05:39PM
08:24AM
Jan-20-24 02:31AM
Jan-19-24 05:45PM
Jan-18-24 03:29PM
12:11PM
10:30AM
09:52AM
05:02AM
Jan-17-24 09:00AM
08:00AM
Jan-12-24 01:51PM
11:45AM
09:00AM
Jan-11-24 11:51PM
10:09PM
05:40PM
04:52PM
04:40PM
03:14PM
03:02PM
02:47PM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah Prem SEVP and Pres-Pharm, Consumer WFeb 16Sale76.9529,4732,267,94739,765Feb 16 06:46 PM
LUDWIG EDWARD JDirectorNov 03Buy70.472,000140,93020,630Nov 06 10:59 AM
Clark James DavidSVP, Cont & Chief Acct OfficerAug 03Sale74.9225,7591,930,0044,698Aug 04 05:41 PM
Lynch Karen SPresident and CEOMay 03Buy69.7514,000976,567431,392May 05 08:27 AM